Dipeptidyl peptidase-4 inhibitors and GLP-1 reduce myocardial infarct size in a glucose-dependent manner

10.1186/1475-2840-12-154

Saved in:
Bibliographic Details
Main Authors: Hausenloy D.J., Whittington H.J., Wynne A.M., Begum S.S., Theodorou L., Riksen N., Mocanu M.M., Yellon D.M.
Other Authors: DUKE-NUS MEDICAL SCHOOL
Format: Article
Published: BioMed Central  2018
Online Access:http://scholarbank.nus.edu.sg/handle/10635/143923
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore
id sg-nus-scholar.10635-143923
record_format dspace
spelling sg-nus-scholar.10635-1439232023-09-21T08:16:16Z Dipeptidyl peptidase-4 inhibitors and GLP-1 reduce myocardial infarct size in a glucose-dependent manner Hausenloy D.J. Whittington H.J. Wynne A.M. Begum S.S. Theodorou L. Riksen N. Mocanu M.M. Yellon D.M. DUKE-NUS MEDICAL SCHOOL 10.1186/1475-2840-12-154 Cardiovascular Diabetology 12 1 154 2018-06-28T02:45:22Z 2018-06-28T02:45:22Z 2013 Article Hausenloy D.J., Whittington H.J., Wynne A.M., Begum S.S., Theodorou L., Riksen N., Mocanu M.M., Yellon D.M. (2013). Dipeptidyl peptidase-4 inhibitors and GLP-1 reduce myocardial infarct size in a glucose-dependent manner. Cardiovascular Diabetology 12 (1) : 154. ScholarBank@NUS Repository. https://doi.org/10.1186/1475-2840-12-154 14752840 http://scholarbank.nus.edu.sg/handle/10635/143923 BioMed Central  Scopus
institution National University of Singapore
building NUS Library
continent Asia
country Singapore
Singapore
content_provider NUS Library
collection ScholarBank@NUS
description 10.1186/1475-2840-12-154
author2 DUKE-NUS MEDICAL SCHOOL
author_facet DUKE-NUS MEDICAL SCHOOL
Hausenloy D.J.
Whittington H.J.
Wynne A.M.
Begum S.S.
Theodorou L.
Riksen N.
Mocanu M.M.
Yellon D.M.
format Article
author Hausenloy D.J.
Whittington H.J.
Wynne A.M.
Begum S.S.
Theodorou L.
Riksen N.
Mocanu M.M.
Yellon D.M.
spellingShingle Hausenloy D.J.
Whittington H.J.
Wynne A.M.
Begum S.S.
Theodorou L.
Riksen N.
Mocanu M.M.
Yellon D.M.
Dipeptidyl peptidase-4 inhibitors and GLP-1 reduce myocardial infarct size in a glucose-dependent manner
author_sort Hausenloy D.J.
title Dipeptidyl peptidase-4 inhibitors and GLP-1 reduce myocardial infarct size in a glucose-dependent manner
title_short Dipeptidyl peptidase-4 inhibitors and GLP-1 reduce myocardial infarct size in a glucose-dependent manner
title_full Dipeptidyl peptidase-4 inhibitors and GLP-1 reduce myocardial infarct size in a glucose-dependent manner
title_fullStr Dipeptidyl peptidase-4 inhibitors and GLP-1 reduce myocardial infarct size in a glucose-dependent manner
title_full_unstemmed Dipeptidyl peptidase-4 inhibitors and GLP-1 reduce myocardial infarct size in a glucose-dependent manner
title_sort dipeptidyl peptidase-4 inhibitors and glp-1 reduce myocardial infarct size in a glucose-dependent manner
publisher BioMed Central 
publishDate 2018
url http://scholarbank.nus.edu.sg/handle/10635/143923
_version_ 1778168724895825920